Sid Singh - 25 Feb 2022 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
President - USIS
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
25 Feb 2022
Net transactions value
-$1,653,976
Form type
4
Filing time
01 Mar 2022, 15:15:35 UTC
Previous filing
24 Feb 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $1,228,328 +8,872 +42% $138.45 30,072 25 Feb 2022 Direct F1, F2
transaction EFX Common Stock Options Exercise $934,768 +7,339 +24% $127.37 37,411 25 Feb 2022 Direct F1, F2
transaction EFX Common Stock Options Exercise $333,498 +3,011 +8% $110.76 40,422 25 Feb 2022 Direct F1, F2
transaction EFX Common Stock Sale $499,267 -2,332 -5.8% $214.09 38,090 25 Feb 2022 Direct F1, F2, F3
transaction EFX Common Stock Sale $731,146 -3,398 -8.9% $215.17 34,692 25 Feb 2022 Direct F1, F2, F4
transaction EFX Common Stock Sale $750,766 -3,458 -10% $217.11 31,234 25 Feb 2022 Direct F1, F2, F5
transaction EFX Common Stock Sale $2,169,393 -10,034 -32% $216.20 21,200 25 Feb 2022 Direct F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -3,011 -100% $0.000000* 0 25 Feb 2022 Common Stock 3,011 $110.76 Direct F1, F7
transaction EFX Stock Option/Right to Buy Options Exercise $0 -7,339 -100% $0.000000* 0 25 Feb 2022 Common Stock 7,339 $127.37 Direct F1
transaction EFX Stock Option/Right to Buy Options Exercise $0 -8,872 -100% $0.000000* 0 25 Feb 2022 Common Stock 8,872 $138.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $213.60 to $214.575, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $214.61 to $215.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $216.66 to $217.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $215.65 to $216.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The option vests in three equal annual increments beginning 2/22/2020.